Shares of Co-Diagnostics, Inc. (CODX) are up more than 5% in the morning trade on Monday at $6.29.
The molecular diagnostics company today said it has shipped testing reagents for monkeypox virus to one of its international distributors.
As of July 7, 2022, over 6,000 cases of monkeypox have been reported to WHO from 59 countries, the company said.
CODX has traded in the range of $3.66-$11.82 in the past 52 weeks.
Source: Read Full Article
Lates News:
-
MicroStrategy To Purchase More Bitcoin From Proceeds Of A $500 Million Stock Sale
-
$BTC: Anthony Pompliano Says ‘In Our Darkest Moment, Bitcoin Steps to the Forefront’
-
BMW Thailand To Use Blockchain Technology For Daily Operations
-
Inflation Anxiety, XRP Fake News Keep Crypto Market Muted
-
Bitcoin Enters Full Accumulation Season, With Shrimps and Whales Seizing Their Share Of The Pie